NANOSONICS LIMITED — Director's Dealing 2017

Nov 23, 2017

==> picture [186 x 67] intentionally omitted <==

24 November 2017

Company Announcements Office Australian Securities Exchange

Appendix 3Y Change of Director’s Interest Notice

Attached is an Appendix 3Y - Change of Director’s Interest Notice in respect of changes in the relevant interests in securities held by Mr Michael Kavanagh, Chief Executive Officer and President.

On 22 November 2017 Mr Kavanagh sold a total of 477,000 Ordinary Shares. The sale of shares by Mr Kavanagh was required to fund a tax liability arising from the vesting and automatic exercise in 2016 of Performance Rights that were granted in 2013 as part of the 2013 Long Term Incentive Scheme and Performance Rights granted as part of the 2015 Short Term Incentive Scheme.

Following this sale, Mr Kavanagh continues to hold 1,328,363 shares. In addition, Mr Kavanagh holds 240,020 Performance Rights and 211,306 Options, which are subject to various vesting conditions.

McGregor Grant Secretary

About Nanosonics

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets. Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. For more information about Nanosonics please visit www.nanosonics.com.au

Nanosonics Limited ABN 11 095 076 896 14 Mars Road, Lane Cove NSW 2066 Australia Tel: +61 2 8063 1600 Fax: +61 2 8063 1600 Email: info@nanosonics.com.au w: www.nanosonics.com.au

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity		Nanosonics Limited
ABN	11	095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	Mr Michael Kavanagh
Date of last notice	18 September 2017

Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	a)Indirect Interestb)Indirect Interestc)Indirect Interestd)Indirect Intereste)Direct Interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	a)PerformanceRightsheldintheNanosonicsEmployee Share OptionPlan.b)Shares held under the NanosonicsDeferred Employee Share Plan (Trust)c)PerformanceRightsheldintheNanosonics Omnibus Equity Pland)OptionsheldintheNanosonicsOmnibus Equity Plan
Date of change	22 November 2017

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	a)206,882 Performance Rights held in theNanosonics Employee Share OptionPlan.b) 1,655,363(Indirect) Ordinary Sharesc)42,138 Performance Rights held in theNanosonics Omnibus Equity Plan.d) 211,306 Options held in the NanosonicsOmnibus Equity Plane) 150,000(Direct)OrdinaryShares
Class	a)Performance Rightsb) Ordinary Sharesc)Performance Rightsd) Optionse)Ordinary shares
Number acquired	Nil
Number disposed	477,000 Ordinary Shares.
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	$1,259,878.63
No. of securities held after change	a)206,882 Performance Rights held in theNanosonics Employee Share OptionPlan.b) Nilc)42,138 Performance Rights held in theNanosonics Omnibus Equity Plan.d) 211,306 Options held in the NanosonicsOmnibus Equity Plane) 1,328,363 (Direct) Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	On-market sale of Ordinary Shares.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

Director: Mr. Michael Kavanagh Date: 24 November 2017

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3